Cancer is a multi-faceted systemic disease that possesses certain issues that make it very challenging to treat for many ...

We have observed substantial anti–tumor activity against a range of tumor types in xenograft models after administration of the C–raf antisense. However, the doses required to achieve anti ...

Researchers from Memorial Sloan Kettering Cancer Center and affiliated organizations revealed ... signaling pathway and is being developed for the treatment of high-grade gliomas (HGGs).

Modifi’s research has produced "compelling preclinical data across a number of tumor models, including patient-derived ...

ETX-197/BG-68501 demonstrated single agent efficacy in a breast cancer xenograft model that had acquired resistance to a CDK4/CDK6 inhibitor. In addition, ETX-197/BG-68501 showed anti-tumor ...